Sniffing a potential new weapon against tough brain tumors
NCT ID NCT05023018
Summary
This study is testing an inhaled therapy called NEO100 for people with aggressive, recurrent meningioma brain tumors that have returned or grown after surgery and radiation. The therapy is a plant-based compound sniffed through the nose four times a day, aiming to deliver treatment directly to the brain. The main goal is to see if it can stop the tumor from growing for at least six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESIDUAL, PROGRESSIVE OR RECURRENT GRADE II OR III MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott and White
RECRUITINGDallas, Texas, 75246, United States
Contact
-
Saint John Cancer Institute
RECRUITINGSanta Monica, California, 90404, United States
Contact
-
University of Southern California
RECRUITINGLos Angeles, California, 90033, United States
Contact
Conditions
Explore the condition pages connected to this study.